DANIELLE ALI: Open Payments
NPI 1437509130 · LANSDOWNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,653 in 19 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $200 · 2025 $1,653
Food & beverage: $1,653
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $499 |
| Teva Pharmaceuticals USA, Inc. | 3 | $158 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $142 |
| Otsuka America Pharmaceutical, Inc. | 2 | $135 |
| Gilead Sciences, Inc. | 1 | $128 |
| Neuronetics, Inc. | 1 | $113 |
| Neurelis, Inc. | 1 | $101 |
| GlaxoSmithKline, LLC. | 1 | $101 |
| Cipher Pharmaceuticals US LLC | 1 | $99 |
| Phathom Pharmaceuticals, Inc. | 1 | $89 |
Products named: Wegovy, Ozempic, AUSTEDO XR, DRIZALMA SPRINKLE, Descovy, NEUROSTAR TMS THERAPY SYSTEM, REXULTI, VALTOCO.
Industry payments across PA — which companies pay providers there.
